Changes in plasma Von Willebrand factor-cleaving protease (ADAMTS13) levels in patients with unstable angina

Thrombosis Research

Volumn 122, Issue 5, 2008, Pages 618-623

  Fuchigami, Shunichiro ^a   Kaikita, Koichi ^a   Soejima, Kenji ^a   Matsukawa, Masakazu ^a   Honda, Tsuyoshi ^a   Tsujita, Kenichi ^a   Nagayoshi, Yasuhiro ^a   Kojima, Sunao ^a   Nakagaki, Tomohiro ^b   Sugiyama, Seigo ^a   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Chemo Sero Therapeutic Research Institute   (Japan)

Author keywords

ADAMTS13; Platelet thrombus formation; Thrombogenicity; Unstable angina; von Willebrand factor; VWF ADAMTS13 ratio

Indexed keywords

VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; THORAX PAIN; THROMBOGENICITY; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; ADAM PROTEINS; ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ANGINA, UNSTABLE; CASE-CONTROL STUDIES; CHEST PAIN; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SYNDROME; VON WILLEBRAND FACTOR;

EID: 49549113339     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.12.025     Document Type: Article

References (23)

1. Mannucci P.M. von Willebrand factor: a marker of endothelial damage?. Arterioscler Thromb Vasc Biol 18 9 (1998) 1359-1362
2. Ruggeri Z.M., and Zimmerman T.S. The complex multimeric composition of factor VIII/von Willebrand factor. Blood 57 6 (1981) 1140-1143
3. Zimmerman T.S., Ruggeri Z.M., and Fulcher C.A. Factor VIII/von Willebrand factor. Prog Hematol 13 (1983) 279-309
4. Sporn L.A., Marder V.J., and Wagner D.D. Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 46 2 (1986) 185-190
5. Montalescot G., Collet J.P., Lison L., Choussat R., Ankri A., et al. Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina. J Am Coll Cardiol 36 1 (2000) 110-114
6. Sixma J.J., Sakariassen K.S., Beeser-Visser N.H., Ottenhof-Rovers M., and Bolhuis P.A. Adhesion of platelets to human artery subendothelium: effect of factor VIII-von Willebrand factor of various multimeric composition. Blood 63 1 (1984) 128-139
7. Sporn L.A., Marder V.J., and Wagner D.D. von Willebrand factor released from Weibel-Palade bodies binds more avidly to extracellular matrix than that secreted constitutively. Blood 69 5 (1987) 1531-1534
8. Libby P. Molecular bases of the acute coronary syndromes. Circulation 91 11 (1995) 2844-2850
9. Heper G., Murat S.N., Durmaz T., and Kalkan F. Prospective evaluation of von Willebrand factor release after multiple and single stenting. Angiology 55 2 (2004) 177-186
10. Lee K.W., Lip G.Y., Tayebjee M., Foster W., and Blann A.D. Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 105 2 (2005) 526-532
11. Montalescot G., Philippe F., Ankri A., Vicaut E., Bearez E., et al. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial. Circulation 98 4 (1998) 294-299
12. Jansson J.H., Nilsson T.K., and Johnson O. von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction. Heart 80 4 (1998) 334-337
13. Thompson S.G., Kienast J., Pyke S.D., Haverkate F., and van de Loo J.C. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 332 10 (1995) 635-641
14. Plaimauer B., Zimmermann K., Volkel D., Antoine G., Kerschbaumer R., et al. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13). Blood 100 10 (2002) 3626-3632
15. Reiter R.A., Knobl P., Varadi K., and Turecek P.L. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin. Blood 101 3 (2003) 946-948
16. Kaikita K., Soejima K., Matsukawa M., Nakagaki T., and Ogawa H. Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction. J Thromb Haemost 4 11 (2006) 2490-2493
17. Matsukawa M., Kaikita K., Soejima K., Fuchigami S., Nakamura Y., et al. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction. Am J Cardiol 100 5 (2007) 758-763
18. Hamm C.W., and Braunwald E. A classification of unstable angina revisited. Circulation 102 1 (2000) 118-122
19. Soejima K., Nakamura H., Hirashima M., Morikawa W., Nozaki C., and Nakagaki T. Analysis on the molecular species and concentration of circulating ADAMTS13 in blood. J Biochem (Tokyo) 139 1 (2006) 147-154
20. Ault K.A., Cannon C.P., Mitchell J., McCahan J., Tracy R.P., et al. Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in myocardial infarction. J Am Coll Cardiol 33 3 (1999) 634-639
21. Merlini P.A., Bauer K.A., Oltrona L., Ardissino D., Cattaneo M., et al. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 90 1 (1994) 61-68
22. Matsumoto M., Kawaguchi S., Ishizashi H., Yagi H., Iida J., et al. Platelets treated with ticlopidine are less reactive to unusually large von Willebrand factor multimers than are those treated with aspirin under high shear stress. Pathophysiol Haemost Thromb 34 1 (2005) 35-40
23. Chauhan A.K., Motto D.G., Lamb C.B., Bergmeier W., Dockal M., et al. Systemic antithrombotic effects of ADAMTS13. J Exp Med 203 3 (2006) 767-776